Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial

Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T03:29:57.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study record history now shows a new revision entry v3.7.0 and removes the previous v3.6.6 entry, updating the version history to reflect the latest documentation update.
    Difference
    0.1%
    Check dated 2026-09-20T01:48:29.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    New revision entry v3.6.6 was added to the study record history, and the previous revision v3.6.5 was removed. This update reflects an adjustment to the version log within the study's history page.
    Difference
    0.1%
    Check dated 2026-08-30T00:32:14.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The sponsor decided to rollover the remaining participants to study PHA022121-C307. The trial was terminated and results were posted, with corresponding updates to Study Status and Outcome Measures.
    Difference
    0.5%
    Check dated 2026-08-22T23:12:21.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.4 to v3.6.5, indicating a new version of the page. This change is limited to metadata and does not modify substantive content or functionality.
    Difference
    0.1%
    Check dated 2026-08-08T23:30:53.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The latest version shows the submission was returned on 2026-07-28 and is under Quality Control Review, with the study history updated to include key sections such as Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, and Study/Recruitment Status.
    Difference
    0.9%
    Check dated 2026-08-01T19:54:50.000Z thumbnail image

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.